BRAF inhibitors-induced panniculitis: a cutaneous side effect mimicking subcutaneous melanoma metastasis

J Eur Acad Dermatol Venereol. 2015 Feb;29(2):392-393. doi: 10.1111/jdv.12397. Epub 2014 Feb 17.

Authors

A Chaminade¹, H Conte², T Jouary², A Fauconneau¹, A-S Darrigade^{1

3}, M Beylot-Barry¹, A Pham-Ledard¹

Affiliations

¹ Service de Dermatologie, Hôpital Haut-Lévêque, CHU de Bordeaux, Univ. Bordeaux, Bordeaux, France.
² Service de Dermatologie, Hôpital Saint-André, CHU de Bordeaux, Univ. Bordeaux, Bordeaux, France.
³ Service de Pathologie, CHU de Bordeaux, Univ Bordeaux, Pessac, France.

PMID: 24533578
DOI: 10.1111/jdv.12397

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use
Female
Humans
Indoles / adverse effects*
Indoles / therapeutic use
Melanoma / drug therapy
Panniculitis / chemically induced*
Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
Skin Neoplasms / drug therapy
Sulfonamides / adverse effects*
Sulfonamides / therapeutic use
Vemurafenib

Substances

Antineoplastic Agents
Indoles
Sulfonamides
Vemurafenib
BRAF protein, human
Proto-Oncogene Proteins B-raf